Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma

O'Day, Steven J.; Eggermont, Alexander M. M.; Chiarion-Sileni, Vanna; Kefford, Richard; Grob, Jean Jacques; Mortier, Laurent; Robert, Caroline; Schachter, Jacob; Testori, Alessandro; Mackiewicz, Jacek; Friedlander, Philip; Garbe, Claus; Ugurel, Selma; Collichio, Frances; Guo, Wei; Lufkin, Joelle; Bahcall, Safi; Vukovic, Vojo; Hauschild, Axel

Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma

Autor(en):

O'Day, Steven J.; Eggermont, Alexander M. M.; Chiarion-Sileni, Vanna; Kefford, Richard; Grob, Jean Jacques; Mortier, Laurent; Robert, Caroline; Schachter, Jacob; Testori, Alessandro; Mackiewicz, Jacek; Friedlander, Philip; Garbe, Claus; Ugurel, Selma; Collichio, Frances; Guo, Wei; Lufkin, Joelle; Bahcall, Safi; Vukovic, Vojo; Hauschild, Axel

Tübinger Autor(en):

Garbe, Claus

Erschienen in:

Journal of Clinical Oncology (2013), Bd. 31, H. 9, S. 1211-1218

Verlagsangabe:

Amer Soc Clinical Oncology

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1200/JCO.2012.44.5585

ISSN:

0732-183X